The Efficacy, Pharmacokinetics and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1 Infected Patients

Erratum

In the article by Rokx et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 68, No. 1, pp. 36-39, entitled “The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1–Infected Patients”, there is an error in the text. In the last sentence of the abstract, it reads: “substituting nevirapine for rilpivirine resulted in ongoing virological suppression…” However, as the authors switched patients from nevirapine to rilpivirine, this should read “substituting rilpivirine for nevirapine”.